Best Crypto Staking Rewards 2026: $GRUNTLE Hits $105k With 8,163% Yield While ET...
Ethereum (ETH) added 2.71% to hold near $1,616.63 over the last 24 hours, but the brief bounce comes after a brutal month that wip...
Abra’s Bill Barhydt says Wall Street’s next crypto bet is tokenization
As Abra prepares for a Nasdaq debut, CEO Bill Barhydt is betting tokenized yield products and onchain lending will drive the next...
AXT (AXTI) Stock Plummets 16% Following CEO’s $22M Share Liquidation Near Peak P...
AXT (AXTI) stock plunged 16% after CEO Morris Young sold over $22M in shares. The price remains far above analyst targets despite...
SK Hynix (000660.KS) Stock Surges After Nvidia Taps It for Vera CPU Memory
SK Hynix stock rises as Nvidia CEO confirms partnership for Vera CPU DRAM. Jensen Huang warns memory shortages will continue for s...
Novo Nordisk (NVO) Stock: Can Amycretin Revive the Struggling Weight-Loss Giant?
Novo Nordisk (NVO) stock analysis: Amycretin phase 2 shows 14.6% weight loss, new Wegovy data at ADA 2026, and pipeline updates af...
Bitcoin risks new 'purge' with bear-market losses still $35B below 2022 total
Bitcoin realized losses remained below the $211 billion tally from 2022, leading to a prediction that the next bear-market bottom...
Realty Income (O) Stock: Does Its Monthly Dividend Still Reign Supreme in 2026?
Realty Income (O) stock raises 2026 guidance to $4.41-$4.44 AFFO per share and increases investment target to $9.5B. Is this month...
NextEra Energy (NEE) Stock: Analysts Bullish on Growth, But Valuation Raises Que...
NextEra Energy (NEE) stock earns Moderate Buy rating after posting 8.2% EPS growth and record renewables backlog, but premium valu...
MercadoLibre (MELI) Stock: Why Major Investors Keep Accumulating Despite Earning...
MercadoLibre (MELI) stock analysis: institutional ownership at 87.62%, Q1 revenue up 49% to $8.85B, EPS misses at $8.23. Analyst t...
Pfizer (PFE) Stock Gains Ground on Once-Monthly Obesity Drug Breakthrough
Pfizer (PFE) stock climbed 1.36% on strong obesity drug data showing 15% weight loss, a $10.5B cancer deal, and vaccine trials ami...